Related Experiment Video

Updated: Jul 26, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

478

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma

Michal Wozniak1, Malgorzata Czyz1

  • 1Department of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland.

Frontiers in Molecular Biosciences
|June 16, 2023
PubMed

Insights

Long non-coding RNAs (lncRNAs) are key regulators of EZH2-mediated gene silencing in melanoma. Targeting the interaction between lncRNAs and EZH2 may offer a novel therapeutic strategy for this lethal skin cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Melanoma incidence is rising globally, posing a significant clinical challenge despite diagnostic and therapeutic advancements.
  • Enhancer of Zeste Homolog 2 (EZH2), a component of the Polycomb Repressive Complex 2 (PRC2), plays a crucial role in epigenetic gene silencing.
  • Aberrant EZH2 activity, driven by activating mutations, contributes to gene silencing during melanoma progression.

Purpose of the Study:

  • To review the current understanding of long non-coding RNAs (lncRNAs) in EZH2-mediated gene silencing in melanoma.
  • To explore the therapeutic potential of targeting lncRNA-EZH2 interactions in melanoma treatment.
  • To discuss potential challenges and controversies associated with this therapeutic approach.

Main Methods:

  • Literature review of current research on lncRNAs, EZH2, and melanoma.
  • Analysis of the role of lncRNAs as specificity factors for EZH2-mediated epigenetic silencing.
  • Discussion of therapeutic strategies targeting lncRNA-EZH2 interactions.

Main Results:

  • lncRNAs act as "address codes" directing EZH2 to specific genomic loci for silencing.
  • Dysregulation of lncRNA-EZH2 interactions contributes to melanoma pathogenesis.
  • Targeting these interactions presents a promising avenue for novel melanoma therapies.

Conclusions:

  • lncRNAs are integral to EZH2's function in melanoma, influencing gene expression patterns.
  • Inhibiting lncRNA-EZH2 interactions offers a potential therapeutic strategy to impede melanoma progression.
  • Further research is needed to address the complexities and potential drawbacks of this approach.
Keywords:
EZH2PRC2epigeneticsimmunotherapylncRNAsmelanomatargeted therapy

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K